Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV6T9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,787
Award facts
- Contract value 100% obligated
- $1,787.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,787.46 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pens. This firm fixed price contract, with an ultimate completion date of December 10, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition without set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order leverages AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX), which is designated as a global pharmaceutical support vehicle running through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. Teriparatide, a hormone treatment used in osteoporosis management, falls within the specialized pharmaceutical portfolio that AmerisourceBergen routinely delivers under its DLA contracts, which encompass diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical commodities.
Quick answers
Who was awarded contract SPE2DR26FV6T9?
SPE2DR26FV6T9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FV6T9 worth?
The government has obligated $1,787 on SPE2DR26FV6T9.
Is contract SPE2DR26FV6T9 an order under another contract?
Yes. SPE2DR26FV6T9 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6T9 competed?
The extent of competition for SPE2DR26FV6T9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award